Introduction 2. Structure-function studies
Leukocyte recruitment is a central event in the pathogenesis of inflammation and recent studies indicate a variety of factors and chemokines which may be responsible for the temporal changes during the response and determine the cellular composition of the infiltrate [1, 2] . We have a long-standing interest in mechanisms involved in accumulation of leukocytes at sites of antigen challenge, particularly in delayed type hypersensitivity (DTH) responses and showed earlier that supernatants of activated murine spleen cells contained a protein of heterogeneous size that caused similar temporal histopathological changes to those typical of antigen-provoked DTH reactions [3] . The purified factor had an apparent molecular mass of 10300 Da and was named chemotactic protein, 10 kDa (CP-10). The partial amino acid sequence indicated that the protein was a member of the S100 family [4] .
The cDNA sequence of CP-10 contains an ORF of 267 bp encoding 88 amino acids of calculated mol wt. 10 163 [5] . The protein contains one putative N-glycosylation site but there is no evidence, by mass spectral analysis, of glycosylation of the native protein from a variety of sources. CP-10 cDNA expressed in E. coli [6] or in a mammalian transient transfection system [5] Murine CP-10 has highest amino acid sequence identity (59%) with the human protein of myeloid origin, macrophage migration inhibition-related protein, MRP8, also known as calgranulin A or S100A8. Pure MRP8 alone, or complexed with the related S 100 protein MRP14, does not affect the migration of human monocytes [7] and is not active in chemotaxis assays performed in parallel with CP-10. The cDNA sequence of murine CP-10 was identical to that of murine MRP8 reported by Lagasse [8] which was derived from a single clone obtained by screening a murine spleen cDNA library with a polyclonal antibody to human MRP8 [9] . The functional relationship of the human and murine proteins is unresolved. Mass spectral analysis indicate that neither native human MRP8 nor native murine CP-10 contain post-translational modifications (M. Raftery, unpublished observations) which may account for these differences. Their relatively low level of amino acid identity is atypical of the highly conserved nature of other proteins in the S100 family [10] . Both proteins have been associated with inflammation [7, 11, 12] . CP-10 was purified as a monomer [4] , the predominant form in neutrophils and activated macrophages. Human MRP8 is usually complexed with a related S100 protein, MRP14 (calgranulin B, S 100A9) and the complex is known as the L1 antigen [13, 14] .
The calcium binding domains of murine CP-10 and human MRP8 share 59% amino acid identity but there is only weak homology (21%) within the 'hinge' region and part of the neighbouring a-helix joining the two calcium binding domains (CP-1042_55). The chemotactic potencies of peptides synthesised according to the amino acid se-quences of equivalent regions of CP-10 and MRP8 were compared and although CP-1042-55 was some hundred-fold less potent than the native protein, MRP843_56 was inactive on human and murine cells, possibly because of predicted differences in secondary structure [5] . Although the full length protein allowed maximal functional activity, this study confirmed the earlier prediction of Kligman and Hilt [10] that, because of the highly conserved structural organisation of the S100 proteins, divergence within the hinge region between different members of the family may determine functional characteristics. In addition, and unlike a number of functions of S100 proteins which apparently depend on dimer formation [10] , monomeric CP-10 is chemotactic.
We have confirmed the ability of CP-10 to bind Ca 2-(P. Alewood and C. Geczy, unpublished data), but its importance in regulating its function is unclear. Attempts to perform the chemotaxis assay in calcium-free conditions resulted in poor overall migration of leukocytes to a range of chemoattractants making data difficult to interpret. Computer-aided molecular modelling indicates that the calcium-bound and free forms of CP-10 are typical of the S100 class, with two well-structured helix-loop-helix motifs. Significant differences were observed between each form and, in contrast to the calbindin structure, the hinge displayed an c~-helical configuration (M. Lackmann, B. Smith, P. Alewood, unpublished data). Ca2+-binding may alter the conformation of the protein to allow optimal interaction of the hinge region with the target cell. CP-10 binds Zn 2+ with relatively low affinity [15] but it has little apparent effect on its chemotactic properties.
Cellular expression of CP-10
CP-10 was originally isolated as a soluble product of Concanavalin A-activated routine spleen cells [4] but was later found as a constitutive cytoplasmic protein in neutrophils from the bone matTow and in elicited neutrophils [6] . Although we reported that elicited murine peritoneal exudate macrophages express low levels of CP-10 mRNA and protein, this may be due to residual neutrophil contamination. CP-10 is apparently not expressed by resting or activated lymphocytes, by fibroblasts or by unstimulated endothelial cells [6] but is an activation product of macrophages [16] and endothelial cells (T. Yen et al., manuscript in preparation). The gene is markedly upregulated in a variety of macrophage populations and in microvascular endothelial cells following activation with bacterial lipopolysaccharide (LPS), indicating that CP-10 may contribute to leukocyte infiltration in gram-negative sepsis. Table 1 summarises the expression of CP-10 mRNA and protein, determined by a sensitive ELISA assay [17] or by Western blotting or immunohistochemistry using a polyclonal antibody with poor reactivity with mMRP14 and no cross reactivity with human MRP8, MRPl4 or bovine S100b. Relative expression of CP-10 mRNA using a eDNA riboprobe as described [15] and of CP-10 protein by ELISA [16] , immunohistochemistry or Western blotting [15] . S100 proteins are expressed in a tissue/cell-specific manner and earlier reports indicate a differentiation-related pattern of expression of the MRP8/14 complex [18, 19] . The two proteins are abundant in neutrophils, with low levels in blood monocytes, but not tissue macrophages whereas the complex is variably expressed in macrophages at sites of inflammation [9, [20] [21] [22] . Our studies indicate that the differentiation state of monocytes/macrophages and endothelial cells, and the nature of the activation triggers, offer additional levels of control of CP-10 gene induction. We have no evidence for constitutive expression of CP-10 in monocytes/macrophages. Induction in murine monocytoid (WEHI 265) and macrophage-like (RAW 264) cell lines occurs via an acquired response involving priming with low doses of LPS followed by challenge with a higher dose [16] . Interestingly, this two-step procedure 'tolerises' RAW cells and other macrophage populations resulting in the suppression of proinflammatory cytokines such as interleukin (IL) 1, IL6, IL8, and tumor necrosis factor a (TNFa) and may represent a regulatory mechanism to limit uncontrolled inflammation [23, 24] . Induction of CP-10 under these circumstances may protect the host from a potential desensitising effect and contribute to the continued recruitment of naive (unprimed) leukocytes with the capacity to produce other important cytokines. Intravenous injection of IL8 downregulates inflammatory responses in the extravasculature [25] . Similarly, release of CP-10 into the bloodstream following initial contact with monocytes with low levels of LPS could promote leukocyte recruitment away from inflammatory sites and the necessity for a second high dose challenge may avoid intravascular activation.
In contrast to the above, as little as 10 ng/ml LPS directly activates CP-10 mRNA in periodate-elicited macrophages [16] . Recent studies indicate that thioglycol-late-elicited macrophages exhibit similar responses and that ILl/3 and TNFce differentially upregulate the CP-10 gene in elicited macrophages (Xu et al., in preparation). Elicited macrophages may be preactivated as a consequence of the recruitment process [26] , so as to respond directly to other signals following migration from the blood. In contrast to RAW and WEH1 cell lines, challenge of LPS-primed, elicited macrophages downregulated CP-10 mRNA expression indicating that particular macrophage populations exhibit 'tolerised' responses similar to those described above for other major macrophage-derived proinflammatory cytokines.
The high levels of CP-10 mRNA expressed in PMN in bone marrow declined rapidly in culture with macrophage colony stimulating factor (CSF-1) a response interpreted by Goebeler et al. [27] to be differentiation-associated. We believe that this is associated with PMN death as the high constitutive levels of mRNA in freshly isolated bone marrow cells decreased to low levels after 4 h culture with or without CSF-1 (Hu, unpublished data). Nevertheless, CSF-1-differentiated bone marrow-derived macrophages (7-10 days) failed to respond directly or after priming and stimulating with LPS [16] further indicating the heterogeneity of macrophage responses. S100 proteins lack putative signal or membrane anchor sequences to direct secretion via classical pathways and, although they are generally located intracellulafly, there is increasing evidence for extracellular functions, [28] . Furthermore, a growing number of cytokines and growth factors without signal sequences are also released by alternate mechanisms apparently independent of cell death [29, 30] . LPS-primed and challenged RAW cells express cell-associated and secreted CP-10. Fig. 1 shows cellular CP-10 is detected 2 h after challenging LPS-primed RAW cells whereas it's appearance in cell-free supernatants is more delayed, beginning 10 h after challenge and reaching similar levels to those found intracellularly, by 24 h. Although LPS priming induced CP-10 mRNA expression, CP-10 was detected by ELISA as described [15] from samples harvested at various times after LPS challenge. 
Expression of CP-10 mRNA detected with a cDNA riboprobe as described [15] . Induction (+), no induction (-), decreased induction ($).
there was little obvious protein and a minimum of 5 h priming prior to challenge was required for protein production [16] . Amounts in supernatants 10 h after LPS challenge were within the chemotactic range and release was not associated with dying cells. CP-10 release was inhibited by cycloheximide suggesting an active transport process different from that recently described for ILII3 secretion from macrophages [31] . Western blotting confirmed that the majority of the CP-10 expressed by RAW cells was monomeric and MRP14 was not found, confirming Northern analysis. Periodate-elicited populations contained CP-10, measured immediately after harvest and possibly due to contaminating PMN, and priming and challenge of these cells with LPS markedly reduced protein levels [16] .
Abscesses (E. coli and B. fragilis) are good models of localised inflammation but mechanisms of control of bacterial growth are still unclear. We separated large amounts of CP-10 and MRP14 as covalent complexes, by affinity purification and this procedure substantially depleted abscess fluid of its chemotactic activity [17] . Immunohistochemistry showed CP-10 throughout the abscess after 7 days. This was expressed in a perinuclear location in PMN in the abscess core and within a population of cells in the outer capsule in a defined region of mononuclear cells as well as in the extracellular spaces. Although CP-10 may have been partially derived from dying PMN within the core it was maintained at high levels over 55 days and, together with the evidence for its induction by LPS, macrophages may have been the major source in chronic lesions [17] and its continued production may contribute to sustained monocyte infiltration to sites of bacterial infection. Table 2 summarises the mediators known to upregulate CP-10 expression in murine periodate-elicited macrophages, the RAW macrophage-like cell line and brain microvascular endothelial cells. MRP8/14 is expressed during terminal differentiation of myelomonocytic cells lines such as HL60 cells differentiated with lot,25-dihydroxyvitamin D3 (Vit D3) or in THP1 monocytic leukemia cells activated with PMA [19] . Vit D3 or calcium ionophore had no effect on CP-10 expression in any of the cells tested and PMA only induced mRNA in periodateelicited cells.
Interferon-~/ is a lymphocyte-derived cytokine pivotal for activation of macrophages in cell-mediated immunity. CP-10 expression in response to interferon-~/ is apparently complex, with direct activation and/or suppression depending on the macrophage, type. CP-10 may be upregulated by inflammatory mediators under a variety of circumstances (eg atherosclerosis, chronic bacterial and parasitic infections) in which macrophages are important effector cells and where cell-mediated immune responses are implicated.
Postcapillary venules are the principal sites for adhesion and extravasation of leukocytes in inflammation. Our earlier immunohistochemical studies indicated CP-10 accumulation around endothelial cells lining small blood vessels 3 h after subcutaneous injection of LPS, with little expression in infiltrating cells [32] . Recent experiments show that LPS and ILl, but not TNFa, directly upregulate CP-10 mRNA and protein in brain microvascular endothelial cells (T. Yen, in preparation). The in vivo studies may reflect differences in the kinetics of induction of CP-10 in endothelial cells and macrophages as both produce optimal responses after culture for approximately 20 h in vitro. The sensitive response to very low doses of ILl suggests that it may be an important mediator in a microenvironment free of LPS. Previous reports proposed that as myeloid cells migrate they secreted MRP8/14 onto the endothelium upon adhesion and became progressively MRP negative as they migrated into inflamed tissue [33] . Although this process may occur in cells expressing these proteins, our studies strongly indicate active expression of CP-10 under proinflammatory conditions and its induction in microvascular endothelial cells supports our proposal for CP-10's involvement in the vascular retention of leukocytes.
spleen cells [15] , MRP14 mRNA was not coexpressed by any of the macrophage populations activated with LPS [ 16] in vitro and its expression may be regulated by other mediators. In contrast, MRP14 mRNA was induced in brain microvascular endothelial cells but we have no evidence of heteromeric complexes with CP-10.
Bacterial abscesses expressed mMRP14 over 55 days, principally as disulphide-linked heterodimers with CP-10 [17] although the cell source of the latter is undefined. The human MRP8/14 complex is antimicrobial and the principal activity is MRP14 [34, 35] which may limit bacterial growth by virtue of its ability to chelate zinc, an essential element for bacterial growth [36] , but we failed to demonstrate antimicrobial activity using pure CP-10 and/or mMRP14 [17] . Human and murine MRP14 are structurally different; mMRP14 has several post-translational modifications including an S-S loop between CYST9 and Cys90 and
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a novel 1-methylation of His106. Both proteins oma Ln with higher affinity than CP10 or S100b and the Zn 2+ binding site/s are apparently distinct and independent of the two Ca 2+ binding domains [15] . Human MRP14 consists of full-length and N-truncated forms, has no internal S-S loop, the free Cys at the N-terminus is absent in the truncated form, has no Me-His residues [15] and the penultimate Thr can be phosphorylated upon PMN activation [20] . Whether the structural differences determine distinct functions for these proteins is unknown. Interestingly, the C-terminal domain of human MRP14 has sequence identity with a peptide which inhibited chemotaxis to classical chemoattractants C5a and FMLP [37] but recent experiments with synthetic peptides showed no effect [38] . Notwithstanding, these proteins may play a role in leukocyte migration and activation as intracellular MRP8 and 14 in human PMN translocate from the cytoplasm to the cell membrane may be involved in highly specific Ca2+-dependent signalling pathways and cytoskeletal changes provoked by classical chemottractants [31, 39, 40] .
CP-IO and MRP14 are not always co-ordinately expressed
Although MRPI4 is also a newly-synthesised protein recently isolated from supernatants of activated murine
Functional characteristics of CP-IO
Chemotaxis is a primitive function of phagocytic cells involved in innate host responses. Recently, two distinct classes of chemoattractants were proposed [41] , because of Table 3 Comparisons of functional responses of neutrophils to chemoattractants a divergence in the ability of some agents to provoke migration in the absence of activation. Like transforming growth factor /3 (TGF/3), CP-10 is more potent than the chemokines or complement-derived chemoattractants, with optimal activity for murine neutrophils (PMN) between 10-12-10 -13 M. Table 3 compares some properties of CP-10 [42] with the classical chemoattractants which stimulate directed migration and activation. TGF/3 [41] and CP-10 belong to the class of 'pure chemoattractants' which provoke actin polymerisation and changes in cell shape but fail to cause degranulation or generate an oxidative burst. Like chemotaxis to FMLP or C5a chemotaxis to CP-10 was mediated by a pertussis toxin sensitive G-protein-coupled pathway but the inability of CP-10 to increase levels of intracellular calcium suggest a mechanism similar to that proposed for TGF[3, which may not involve G-protein pathways coupled to phosphotidylinositol-or phosphotidylcholine-linked phospholipases. A number of reports suggest that leukocyte migration can proceed without increments of [Ca 2÷ ]i [43, 44] and our studies support the notion of independent signal transduction pathways for migration and activation in leukocytes. Interestingly, the mechanism of action of CP-10 is apparently different from that required for the changes in glial cell morphology, cytoskeletal reorganisation and possibly growth cone mobility promoted by extracellular S 100b which causes rapid increases in (Ca2+)i in glial and neuronal cells [45] . Polymerisation of F-actin is a central event in cell migration and reorganization from monomeric G-actin to F-actin occurred after 30 s incubation with CP-10 in both PMN and WEHI 265 monocytoid cells [42] . Increases in F-actin correlated with changes in cell shape after 30-60 s and profound changes were observed if WEHI cells were incubated with CP-10 for 90 min. This effect was stronger than that described for TGFI3 [46] and more apparent with adherent cells, although the potential for costimulation by ligation of adhesion receptors, which causes slow and persistent actin polymerisation [47] , has not been fully investigated.
The expression and function of adhesion receptors on leukocytes is upregulated by the classical chemoattractants and in accordance with the inability of CP-10 to cause degranulation, CDllb (Mac-l) was not upregulated directly by CP-10 although CP-10 recruited-leukocytes express increased levels. Leukocyte retention in microcappilaries is an important event in the initiation of inflammation in vascular beds. This may occur through geometric constraints caused by increased cell size and stiffening, principally due to increased F-actin, particularly in pseudopodia, and to the formation of stress fibres [44, 48] . Our studies using confocal microscopy showed that CP-10 increased the size of WEHI cells by 3-to 10-fold and of PMN by 4-fold, to areas which could readily block microcapillaries, and the monocytoid cells formed long fingerlike lamellipodia with intensely-stained F-actin stress fibres. The rapid retention of PMN in pulmonary capillaries following administration of LPS is not dependent on CD 11/CD ! 8-mediated adhesion [48, 49] , and because appropriately activated endothelial cells express CP-10, this may mediate the early vascular response. The inability of CP-10 to directly initiate L-selectin shedding may be important in the initial binding of leukocytes to the microvascular endothelium prior to transmigration. Increase deformability could contribute to ischemic events in disorders such as sepsis, post-traumatic shock and myocardial infarction.
Activity of CP-IO in vivo
The histopathological changes and the macrophage phenotype recruited by CP10 are distinct from those described for other chemoattractants and chemokines. CP-10 and the hinge region peptide (CP-1042_55), elicit leukocyte recruitment in vivo. Variations in the responses at different injection sites have been observed and may reflect the composition of the microenvironments and/or peptide localisation and clearance. Optimal concentrations (recombinant CP-10, 10 -7 M; CP-1042_55, 10 -6 M) required to provoke recruitment [32] are higher than for chemotaxis in vitro and potencies are similar to those described for some rat chemokines in vivo [49] . Approx. 10-times more CP-1042_55 is required to elicit a peritoneal infiltrate than when injected s.c.
Footpad injection with rCP-10 causes an intense infiltration of PMN after 3 h which peaks after 8 h followed by a mixed mononuclear infiltrate more obvious after 12 h [5, 32] . The increased expression of CD 1 lb (Macl integrin) and decreased L-selectin on elicited leukocytes enhances their tight adhesion to the vasculature and promotes transmigration [50] . The PMN infiltrate elicited by CP-10 were Mac-1 high and L-selectin low [32] , characteristics similar to those of PMN elicited by classical factors such as FMLP and IL8 [50, 51] . Similar kinetics were observed following intraperitoneal injection of CP-1042_55 with an absolute increase in monocyte/macrophage numbers of approximately 5-fold after 24 h [52] . Table 4 summarises some of the properties of CP-10-elicited murine Table 4 Characteristics of CP-10-elicited macrophages Enlarged size, increased vesicles, endoplasmic reticulum, pseudopodia F4/80 antigen low CD1 lb/CD18 high $ Scavenger receptor ~" TNFa production J, Nitric oxide production "r AcLDL loading ~ foam cells $ Phagocytosis Characteristics of monocytes recruited over 16-36 h following i.p. injection of mice with CP-1042_55. Expression higher (~') or lower (,1,) as described (Lau) than on macrophages from mice injected with diluent control. macrophages. The observed changes were not all due to the direct effect of CP-10 oil these cells and secondary, as yet uncharacterised mediators, probably contribute to its in vivo effects. In contrast to resident peritoneal macrophages which express high levels of the macrophage-specific antigen F4/80, the low level on CP-10-elicited macrophages suggests activation and these cells are larger and more vacuolated than resident macrophages [52] . Apart from the coordinated upregulation of CDllb/CD18, LFA-1 and VLA-4 integrins were not altered confirming these as newly-recruited cells [53] . Moreover, levels of scavenger receptor were markedly higher than those expressed on macrophages elicited by other agents including thioglycollate and CSF1 and CP-10-elicited macrophages accumulated significantly greater levels of cholesterol esters, a reflection of lipid loading [54] , in response to acetylated low density lipoprotein (AcLDL) in vitro and in vivo. Scavenger receptor activity increases with macrophage maturation and differentiation and is thought to contribute to potential foam cell dew,qopment [55, 56] . Furthermore, CP-10-elicited macrophages express high levels of Fc receptors and are strongly phagocytic (Lau et al., in preparation), additional parameters indicative of an activated phenotype. Ours was the first demonstration of macrophage foam cell formation in an experimental system in vivo and the cholesterol ester profiles of extracted lipids were similar to those of cells freshly isolated from human atherosclerotic plaque [52] .
The data presented strongly implicate CP-10's involvement in leukocyte recruitment and retention within the microvasculature in inflammation. Upregulation of CP-10 by LPS and ILl in macrophages and endothelial cells suggest its importance in non-specific and immune-mediated conditions and it may provide an important host response in gram-negative bacterial infection. In addition to its potent chemotactic activity, CP-10 may also contribute to the inflammatory response by its capacity to modulate the activation state of recruited leukocytes. CP-10-elicited macrophages are activated and can form foam cells, strongly implicating its involvement in atherogenesis, and these cells may have additional important effector functions. CP-10 may act with other chemokines, to contribute to amplification mechanisms required for the sustained recruitment of monocytes in chronic inflammatory conditions.
